학술논문
Pooled overall survival and safety data from the pivotal phase II studies (NP28673 and NP28761) of alectinib in ALK-positive non-small-cell lung cancer
Document Type
Article
Author
Source
In: Lung Cancer . (Lung Cancer, January 2020, 139:22-27)
Subject
Language
English
ISSN
18728332
01695002
01695002